Mor, S. et al. 2022. Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation, and docking studies of N’-arylidene-2-((7-methylbenzo[4,5]thiazolo[2,3-c] [1,2,4]triazol-3-yl)thio)acetohydrazides. European Journal of Chemistry. 13, 4 (Dec. 2022), 426–434. DOI:https://doi.org/10.5155/eurjchem.13.4.426-434.2315.